References
- Khalil DN, Smith EL, Brentjens RJ, Wolchok JD. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy. Nat Rev Clin Oncol. 2016;13:273–11. doi:https://doi.org/10.1038/nrclinonc.2016.25.
- Tabas I, Glass CK. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science. 2013;339:166–72. doi:https://doi.org/10.1126/science.1230720.
- Graham BS, Ambrosino DM. History of passive antibody administration for prevention and treatment of infectious diseases. Curr Opin HIV AIDS. 2015;10:129–34. doi:https://doi.org/10.1097/COH.0000000000000154.
- Weiner GJ. Building better monoclonal antibody-based therapeutics. Nat Rev Cancer. 2015;15:361–70. doi:https://doi.org/10.1038/nrc3930.
- Herceptin prescribing information [cited 2019 Sept 22]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103792s5345lbl.pdf.
- Avastin prescribing information [cited 2019 Sept 22]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125085s331lbl.pdf.
- Remicade prescribing information (1998) [cited 2019 Sept 22]: https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/inflcen082498lb.pdf.
- Remicade prescribing information (2018) [cited 2019 Sept 22]: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103772s5385lbl.pdf.
- Arvinte T, Palais C, Green-Trexler E, Gregory S, Mach H, Narasimhan C, Shameem M. Aggregation of biopharmaceuticals in human plasma and human serum: implications for drug research and development. MAbs. 2013;5:491–500. doi:https://doi.org/10.4161/mabs.24245.
- Luo S, Zhang B. Dextrose-mediated aggregation of therapeutic monoclonal antibodies in human plasma: implication of isoelectric precipitation of complement proteins. MAbs. 2015;7:1094–103. doi:https://doi.org/10.1080/19420862.2015.1087636.
- Kinderman F, Yerby B, Jawa V, Joubert MK, Joh NH, Malella J, Herskovitz J, Xie J, Ferbas J, McBride HJ, et al. Impact of precipitation of antibody therapeutics after subcutaneous injection on pharmacokinetics and immunogenicity. J Pharm Sci. 2019;108:1953–63. doi:https://doi.org/10.1016/j.xphs.2019.01.015.
- Burgess RR. Protein precipitation techniques. Methods Enzymol. 2009;463:331–42.
- Maurer RW. Sandler SI and Lenhoff AM. Salting-in characteristics of globular proteins. Biophys Chem. 2011;156:72–78. doi:https://doi.org/10.1016/j.bpc.2011.02.002.
- Demeule B, Palais C, Machaidze G, Gurny R, Arvinte T. New methods allowing the detection of protein aggregates: a case study on trastuzumab. MAbs. 2009;1:142–50. doi:https://doi.org/10.4161/mabs.1.2.7632.
- Arvinte T, Poirier E, Palais C. Prediction of aggregation In Vivo by studies of therapeutic proteins in human plasma. In: Rosenberg A, Demeule B, editors. Biobetters: protein engineering to approach the curative. New York: Springer New York; 2015. p. 91–104.
- Arvinte T, Cudd A, Palais C, Poirier E CHAPTER 11 The Formulation of Biological Molecules. Pharmaceutical Formulation: The Science and Technology of Dosage Forms: The Royal Society of Chemistry, 2018:288–316.
- Joubert MK, Hokom M, Eakin C, Zhou L, Deshpande M, Baker MP, Goletz TJ, Kerwin BA, Chirmule N, Narhi LO, et al. Highly aggregated antibody therapeutics can enhance the in vitro innate and late-stage T-cell immune responses. J Biol Chem. 2012;287:25266–79. doi:https://doi.org/10.1074/jbc.M111.330902.
- Lutz RJ, Dedrick RL, Boretos JW, Oldfield EH. Blacklock JB and Doppman JL. Mixing studies during intracarotid artery infusions in an in vitro model. J Neurosurg. 1986;64:277–83. doi:https://doi.org/10.3171/jns.1986.64.2.0277.
- Blacklock JB, Wright DC, Dedrick RL, Blasberg RG, Lutz RJ, Doppman JL, Oldfield EH. Drug streaming during intra-arterial chemotherapy. J Neurosurg. 1986;64:284–91. doi:https://doi.org/10.3171/jns.1986.64.2.0284.